Continue to Site »
Site will load in 15 seconds
Advertisment: Fluence » Fluence Order 95 » CBT ROS Banner 970x250 May 2025 - Start May 21 » FLU-DBA_Services_Hort_Cannabis_970x250

MedPharm Awarded Colorado's First Cannabis Research License

The cannabis research license was created by the state to allow cannabis-related operators and researchers to study the plant and better understand what it offers.


DENVER--(BUSINESS WIRE)--PRESS RELEASE--MedPharm, a medical cannabis grow, R&D laboratory and compounding facility, has announced that it has been awarded the first cannabis research license by the state of Colorado. To get the license, the state looked at the applicant’s capabilities to successfully develop and conduct research.

Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies 2026 ROS Parallax Reveal » bcc-ads-730x570
Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies 2026 ROS Parallax Reveal » bcc-ads-730x570

The cannabis research license was created by the state to allow cannabis-related operators and researchers to study the plant and better understand what it offers. The application for the license included outlining research objectives and creating areas where medical research cannabis is grown specifically for research purposes.

Advertisment: Hanwha Vision » Hanwha Vision Order 78 » CBT ROS 300x250 Medium Rectangle June 2025 » Hanwha January Ad

“We have a strong research team of some of the best and brightest in the industry, and this cannabis research license will really help us in our quest to be a world leader in dosage formulation and product development,” Albert Gutierrez, CEO of MedPharm, says. “We are eager to look at what benefits the plant might offer for improving the human condition.”

Advertisment: Hanwha Vision » Hanwha Vision Order 78 » CBT ROS 300x250 Medium Rectangle June 2025 » Hanwha January Ad

Dr. Tyrell Towle, the director of chemistry for MedPharm with a PhD in medicinal and natural products chemistry, says that the cannabis research license will enable MedPharm to provide their high-quality dosage forms directly to study patients. “It will also allow us to perform Randomized Controlled Trials (RCTs) because we can supply placebos as well, which wasn’t previously allowed for,” he says. “We are now in a better position than any cannabis company to take on research partnerships and we welcome those who are interested in such partnerships.”

MedPharm currently makes three brands: Aliviar, a medically-focused brand that produces pharmaceutical grade dosage forms (www.aliviaralleviates.com); Become products for a mellow, balanced or elevated feeling (www.becomelifestyle.com); and Batch, an oil concentrate with higher percentages of THC for the cannabis connoisseur (www.batchextracts.com). “Our recent review of our strains shows a very rare and unique cannabinoid that we originally dismissed as interference. We were able to identify the cannabinoid and see its molecular structure, which is exciting,” Towle says.

Advertisment: Hydrofarm » Hydrofarm Order 113 » CBT ROS 300x250 Medium Rectangle » PhotoBio MX2 Med Rectangle Ad
Advertisment: Hanwha Vision » Hanwha Vision Order 78 » CBT ROS 300x250 Medium Rectangle June 2025 » Hanwha January Ad
Page 1 of 58
Next Page
Advertisment: Greentank » Greentank Order 92 » CBT ROS Mobile Adhesion 360x120 June 2025 » cbt-mobile-gt-shop